ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000895.1|Citrulline_1 # 3 # 377 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.461	BGC0000895.1|Citrulline_1 	3	377	+	Loose	750	24.6386	adeF	41.67	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GCAACGGACTATTTGGTAACTGTTAAGTTATACCTGGGCTTTCGTGTCCGCCAAGATATTAACCGCTATTTACGGACGATTGTCCGCGACTTAATGGCTACTGGACGTTTAGCGGCGCAAAAGCAGACATATTCAGTCACTTCTGGCCGCGATGTCGGTGACTTCCGCTTCGTTATCATCGAGGAGAAGTTAGAAAATGGTAGTCGGTTATCCCGCTTGGATCGATTAGTGATCGAGACGAAATTAATGATTAAAAAATACGCGACAACGCCTGCCAAATGGTTCGGCCTAGAATTCTCCGAGGTGACTCTTGAAACCGTTCCAATTCTATTCAACGAGATCCCGGCGTTACCGATCACTGAAAGACAACGTTAA	ATDYLVTVKLYLGFRVRQDINRYLRTIVRDLMATGRLAAQKQTYSVTSGRDVGDFRFVIIEEKLENGSRLSRLDRLVIETKLMIKKYATTPAKWFGLEFSEVTLETVPILFNEIPALPITERQR	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	11.71	gnl|BL_ORD_ID|132|hsp_num:0	153			2244	2316	tetracycline
BGC0000895.1|Citrulline_2 # 484 # 3546 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.501	BGC0000895.1|Citrulline_2 	484	3546	-	Loose	275	38.891	vanE	21.74	3002907	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	ATGCCTAAAAACAATGCCATTCATTCGATTGCTGTCATCGGTTCTGGTCCAATCAAAATCGGTCAAGCCGCTGAGTTCGACTATGCCGGTACTCAGGCTTGTCTAAGCCTTAAAGCGGCCGGCTATCATGTCATTTTGATCAATTCAAACCCAGCAACCATCATGACTGACACGGCCACCGCCGACGAAGTCTACTTAGAACCTCTGACTTTGACCAGTGTCACTAAAATTCTGCGGGCCACCCACCCTGATGCTTTGCTCCCGACACTTGGTGGACAAACCGGATTGAACCTAGCGATGGCGTTAGATCAGGCTGGCGTTCTTAATGAGTTGAAGATCCAACTGCTAGGAACTTCCCTAGCCACCATCAATCAAGCTGAAGACCGGGCAGCATTTAAAACACTTATGAAGCGGCTCCATCAACCGATTCCAGCAAGTACCACTGTTCACCACGTGACCAGTGCATTGTCGTTTGCTGAAAAAATCGGTTATCCGGTCATTGTTCGTCCAGCCTTTACACTCGGGGGTTCAGGTGGTGGCATTGCCAATAATGCCGCCGAATTGACCCAAACGTTACAGCGGGGGCTGACCATGTCCCCCGTCACCGAGTGCCTGATTGAACAAAGTATCGCCGGCTTCAAAGAAATTGAATTCGAAGTCATGCGTGATAATCAGGGTACCAAGATCATCGTCTGTTCCATGGAAAACTTCGATCCGGTCGGTATTCACACTGGCGATTCTATCGTGTATGCCCCCGTTCAGACTTTGACTGACACTGAATATCAGCAGCTACGAACGGCGGCTTTGACGATTGTGGAAGCCCTCGACATTAGAGGTGGGTGCAACGTTCAACTCGCTCAAGACCCGAATAGTCGTCAGTACTACGTCATCGAAGTGAACCCGCGGGTCAGTCGTTCATCGGCGCTAGCTTCTAAAGCGACGGGATATCCAATTGCCAAAATTGCAGCCGATATCGCAATTGGTCTAAATTTATCTGAGATCAAGAATCCAGTCACGCAGACAACCTACGCGGCCTTTGAACCAGCTTTAGACTATGTGGTTGCCAAAATCCCCCGGTTTGCGTTTGACAAGTTTCCAACGGCCGACGCTCACTTGGGAACACAGATGAAAGCCACGGGGGAGGTCATGGCGATTGGGTCAACCTTGGAGGAAGCCACGCTCAAGGCGATTGCTTCGCTTGAAATCGATCCCAAGACCCAAGCGTCCTTGACCCCTGACCACCACGTCACCACGACTGAATATATCGACCAATTGACCCACCCGACAGATCAGCGGCTCTTCTATCTATTGGCGGCGCTGCAAGCGGGTTGGCCGTTAGCAAAATTAGCGACGCTAACGCAAATCACGCCATTTTTCTTGAGTAAGTTACAGCACATCGCCCAACTCATCCGGAATATCAAGCAAGTGCCGACGTCCCAACACCTCTTATCGGCGAAAAAGTACGGTGTGAGTCTGGCGACCATGGCGCATTATGCCCAAACTTCGGTAGCGACCATTGCTGCCATGACTGCTGATTTACCCTTCGTTTATAAAATGGTCGATACGTGTGCTGGTGAATTTGCCAGTGTTACACCATATTTTTACAGCACTGCTTTTGGACAAACTAACGAGAGTCACCCACTAGGACACAGTATTTTAGTACTCGGATCAGGCCCCATTCGAATCGGACAAGGCATCGAATTCGACTACACCACCGTTCACTGTGTCAAGGCCATTCAACAAGCTGGCTACCATGCAATCATCGTCAATAACAATCCCGAGACGGTCTCCACCGACTTTTCTACCTCGGATAAGCTTTATTTCGAGCCACTAACAATCGAACGTTTGATGCCAATCATTGCGTTGGAGCAACCCGCGGGCGTCATCGTTCAATTTGGGGGCCAAACTGCGATCAACCTTGCCCATCAGCTCACTAAATTAGGAGTCACCGTCCTAGGAACCAGTGTGTCCGCTACCGATTTGACCGAAGACCGGCAATCTTTTGCGGACTGTTTACGTCTACTAAAGATTGCCCAAGCCGCTGGAACGACCGTAACTGAGTTATCCGGTGCCCGTCAAGCAGCTCACGCAATCGGTTACCCCTTACTCGTACGGCCAAGCTTTGTACTCGGCGGCCGGGCCATGGCAATCGTTCATAACGATCATGAGCTCACGCCAGTTATTAAATCAGCGGTGGCAGCTGGCCATGGTGCGCCTATCTTAATGGACCAATACTTGGCGGGAACCGAGTGTGAAGTTGACGTTCTCTCCGACGGAACGTCGTGCTTCATTCCAGGAATCATGGAACATATTGAAGGTGCTGGCGTTCATTCTGGCGATTCCATTACAGTCTATCCACCACAGCACCTCAGCCCTGCTGTTCAAGATAAGATCGTCACCATTGCCACCAAATTAGCACAACACCTCCACTGTGTCGGTATGATGAACATTCAGTTCGTCGTCACCGATGATGTCTACGTAATCGACGTTAATCCGCGGGCAAGTCGAACAGTTCCTTACATGAGCAAGGTTACTCACTTGCCACTGGCACAATTGGCAACCCGGCTAATTCTCGGTCAAAGTTTAGCAACCCTTGGCCTAGTCCCCGGACTCTTGACACCCGCTCCACAACAAATTGCTATAAAGGCCCCAGTCTTCTCTTTCAATAAATTGCCACAATCACCAGTCGTTTTAAGTCCTGAGATGAAATCAACTGGTGAGACTCTTGGTATCGGCCCGACTTTCACGACCGCTTGGCATGCCGCCATGGCTGATAGTTATCACTTAGAGACTTGGCAAACCGTGGATGGTCTCATCACCGATATTGCCACTGTGGCGCAACCCGCGGTCCAGGAACTGTTCGCGGCTAACCACCTCACCGTCACAACAATCGCTAACACGACTGATTGGCCTGCAAAGACTAAAGCAGTGGGTTTCACGCTTAATGACCAACCTGACAATCCCGTGGCTATCGCTGCATTGAATCATGGACAACCATTGATTACGGCGATTGATACCTTAAAAACATTATTAGCAGTAACACCAACCCCAGCTACCATCTAA	MPKNNAIHSIAVIGSGPIKIGQAAEFDYAGTQACLSLKAAGYHVILINSNPATIMTDTATADEVYLEPLTLTSVTKILRATHPDALLPTLGGQTGLNLAMALDQAGVLNELKIQLLGTSLATINQAEDRAAFKTLMKRLHQPIPASTTVHHVTSALSFAEKIGYPVIVRPAFTLGGSGGGIANNAAELTQTLQRGLTMSPVTECLIEQSIAGFKEIEFEVMRDNQGTKIIVCSMENFDPVGIHTGDSIVYAPVQTLTDTEYQQLRTAALTIVEALDIRGGCNVQLAQDPNSRQYYVIEVNPRVSRSSALASKATGYPIAKIAADIAIGLNLSEIKNPVTQTTYAAFEPALDYVVAKIPRFAFDKFPTADAHLGTQMKATGEVMAIGSTLEEATLKAIASLEIDPKTQASLTPDHHVTTTEYIDQLTHPTDQRLFYLLAALQAGWPLAKLATLTQITPFFLSKLQHIAQLIRNIKQVPTSQHLLSAKKYGVSLATMAHYAQTSVATIAAMTADLPFVYKMVDTCAGEFASVTPYFYSTAFGQTNESHPLGHSILVLGSGPIRIGQGIEFDYTTVHCVKAIQQAGYHAIIVNNNPETVSTDFSTSDKLYFEPLTIERLMPIIALEQPAGVIVQFGGQTAINLAHQLTKLGVTVLGTSVSATDLTEDRQSFADCLRLLKIAQAAGTTVTELSGARQAAHAIGYPLLVRPSFVLGGRAMAIVHNDHELTPVIKSAVAAGHGAPILMDQYLAGTECEVDVLSDGTSCFIPGIMEHIEGAGVHSGDSITVYPPQHLSPAVQDKIVTIATKLAQHLHCVGMMNIQFVVTDDVYVIDVNPRASRTVPYMSKVTHLPLAQLATRLILGQSLATLGLVPGLLTPAPQQIAIKAPVFSFNKLPQSPVVLSPEMKSTGETLGIGPTFTTAWHAAMADSYHLETWQTVDGLITDIATVAQPAVQELFAANHLTVTTIANTTDWPAKTKAVGFTLNDQPDNPVAIAALNHGQPLITAIDTLKTLLAVTPTPATI	MKTVAIIFGGVSSEYEVSLKSAVAIIKNMESIDYNVMKIGITEEGHWYLFEGTTDKIKKDRWFLDESCEEIVVDFAKKSFVLKNSKKIIKPDILFPVLHGGYGENGAMQGVFELLDIPYVGCGIGAAAISMNKIMLHQFAEAIGVKSTPSMIIEKGQDLQKVDAFAKIHGFPLYIKPNEAGSSKGISKVERKSDLYKAIDEASKYDSRILIQKEVKGVEIGCGILGNEQLVVGECDQISLVDGFFDYEEKYNLVTAEILLPAKLSIDKKEDIQMKAKKLYRLLGCKGLARIDFFLTDDGEILLNEINTMPGFTEHSRFPMMMNEIGMDYKEIIENLLVLAVENHEKKLSTID	289.77	gnl|BL_ORD_ID|1478|hsp_num:0	1617			507	960	vancomycin
BGC0000895.1|Citrulline_3 # 3539 # 4606 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.516	BGC0000895.1|Citrulline_3 	3539	4606	-	Loose	300	25.409	tet(32)	36.11	3000196	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAACAAATACTTAACTTTAGCGGACGGCACACAGTGGATTGGAACGGCAATTGGGGATTGCCAGCTAGAGGTTGCGGGGCGCATCGTCTTCAATACGGGAATGACGGGTTATCAGGAAACATTGACTGATCCATCCTACCTAAATCAAATGATTGCCTTCACTTACCCATTAATTGGTAATTATGGTATCGATCCGACCGTGGCCCAGGCACCAACGATTGGCGCACAAGCCATCATCGTTCACGAGCTGACCACTTTTAATGATCACTATACTAGTCGCCAATCACTGGCAAGTTTTCTGACAATCCACCATGTAGCCGGCATTGAAGGCGTCGATACTCGTGACCTAACGATTCACATTCGCCAAACGGGAGCCCAGATGGCAATCTTGAGCAATCATCCCATCACTGATTTTGAAGCGCAACTCGCCACATTCGCACCCCAAGTACTAACGGCTACCCCCCTCCCAGTAGCGACGACCACCATCCGTCCACGCGTCGCGATTCTCAACTTTGGTGAAAAAGCAGCTATCACCGCTGAATTGCAAGCCCGGGGCGCGGACGTTGTTGTCCTTCCACCTACAGCTAGTCTCAAGGCCGTGGCCGCGTATCACCCTGACGGAATTTTGTTATCCAACGGTCCCGGTGATCCGACCGACTATCACACTTACTTAGCGACCATTCGCCAACTCGCACAACGTTATCCGCTGGCTGGCATTTGCCTTGGTCATCAGTTGATTGCGCTCGCCTATGGTGCTCAGACTTACCAGCTTTCCTTTGGTCACCACGGGCTAAACCATCCGGTACAAGCCTGCGCTGACGGTCGTATTATCATGACTTCGCAAAATCATGATTACGCCGTCGATCCGGCATCGATCAAGGGCACCCCGCTGATCGTCACGCACACTGAATTAAATGACGGCAGCATTGAAGGCTTGCGCCTACCGCACCAGGCCGTAATGTCGGTGCAATTCCATCCCGAAGCACACCCGGGACCCCAGGAAGCTGGGCAATTTTTCGATGATTTCTTACTAACAATTCAAAAGGAGGCGGTTGTTAATGCCTAA	MNKYLTLADGTQWIGTAIGDCQLEVAGRIVFNTGMTGYQETLTDPSYLNQMIAFTYPLIGNYGIDPTVAQAPTIGAQAIIVHELTTFNDHYTSRQSLASFLTIHHVAGIEGVDTRDLTIHIRQTGAQMAILSNHPITDFEAQLATFAPQVLTATPLPVATTTIRPRVAILNFGEKAAITAELQARGADVVVLPPTASLKAVAAYHPDGILLSNGPGDPTDYHTYLATIRQLAQRYPLAGICLGHQLIALAYGAQTYQLSFGHHGLNHPVQACADGRIIMTSQNHDYAVDPASIKGTPLIVTHTELNDGSIEGLRLPHQAVMSVQFHPEAHPGPQEAGQFFDDFLLTIQKEAVVNA	MKIINIGILAHVDAGKTTLTESLLYTSGAIAEQGNVDKGTTRTDTMILERQRGITIQTAVTSFYWNDYKINIVDTPGHMDFLTEAYRSLSVLDGAVLVISAKDGVQAQTRILFHALQKMDIPTIIFINKIDQNGIDLQCVYQSIKDKLTSDMIVMQEVSLSPKITMTDISDLDKWDMIISGSDELLERYVAEDSLDIQELQYEKCKRTRCCSLFPVYHGSAKDNLGTEKLIEAIIETFITETDDIQSELCGYVFKVEYTERKKRLSYLRLYHGTLHLRDTLLLSKKEKIKITEMCIPSNGEIVPADHACPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREALLNALAEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIYLERPQKKASCTIHIEVPPNPFWASIGLTVTPLPVGSGTQYKSEVSLGYLNQSFQNAVMEGVRYGMEQGLYGWGVTDCQICFDYGVYYSPVSTPADFRFLAPVVLEQALKKAGTQLLEPYLSFTLFAPQEYLSRAYNDAPKYCAIIESTRLEKDEVIFKGEIPARCIGEYRNDLNFYTNGRSVCITELKGYQETSGEPVFQPRRPNSRLDKIRHMFQKIM	55.56	gnl|BL_ORD_ID|1220|hsp_num:0	1233			1749	1857	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0000895.1|Citrulline_5 # 5924 # 7138 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.473	BGC0000895.1|Citrulline_5 	5924	7138	+	Loose	500	26.5646	OXA-917	30.51	3006103	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGCAGATGCAAGTTTTAACGAATACGAAGTTTGAAACGGTTGCCTTTCAGTGGCCGGCAGGTTTTTACAGTGATGGCATTCATATTGGTCTTCGTCGTCATAAAAAAGATTTTGGTTGGCTATTTTCAAAAGTGCCTGCCAGTGCGGCTGGAACTTATACGACGAATCAGTTTCAGGCAGCACCAACTAAGTTAACTAAACAGATGATCGACCAGGGCCACCAATTACAGGGACTGCTGCTGAACAGTGCAATCGCCAATTCTTGTACTGGCGAGCAGGGGTGGCAGAATGCGCTGCAAGAACAAGCCTGGTTAGCGAATAAACTAAACGTGGCGCCGAACTTGATTGGCGTTGCTTCAACTGGGCTGATTGGTGCTCAGTTACCCATGGATAAAATCAAAAACGGCTTGCCGCAATTGACCCCAACGAAGAGTGACGCGGTGACCTACGCCGTGTTAACGACAGACCAGCATCCAAAAACCGTCTGTGTGCAGTGTGAACTCAGCGGCCAGTTAGTTACCTTGACCGGTTTTGCCAAAGGTTCTGGAATGATTCATCCCAAGATGGCAACCATGCTTGGTTTTGTCACCACTGATGCCCAAATAGATGGGCCAGTTTTACAGGACATGCTAAGTACTAACGTTGATCAGACATTCAATCAAATTACTGTTGACGGTGACACGTCTACTAATGACATGGTGGTCACGTTGGCAAATGGTCTGGCAGATAATCCGAGTTTACAAGCGGGTACCACCGACTATGATATTTTTAATCAGGCGTTGCACTATGTCTTAGGCCAACTTGCCAAGCAAATTGCCGCTGACGGTGAGGGTGCGACCAAGTTAGTCGAATGTAATGTGGTCCACGCCGCTACAACGTTTGATGGTCAGCAAATCGCCAAAGCAATTGTTGGCTCTAACCTCGTTAAGGCGGCCATTTTCGGTGAAGACCCGAATTGGGGGCGAATCATTAGCACGATTGGCGCCACTGATGCAGACATCGATGTGGCGACGGTCGATATTGAAATGAACGGCGTTTTACTTGTTCAACAAAGTCTGGCCGTTGACTTTGATATGGCAGCGGTGCAGGCGACCTTACGTGATAACCAGATTATGATCGATGTTGATTTACATCACGGTACAGCAAGTGGTCAGGCTTGGGGTTGTGACTTGACTTACAACTACGTCAAAATTAACGCGAGCTATCATACTTAA	MQMQVLTNTKFETVAFQWPAGFYSDGIHIGLRRHKKDFGWLFSKVPASAAGTYTTNQFQAAPTKLTKQMIDQGHQLQGLLLNSAIANSCTGEQGWQNALQEQAWLANKLNVAPNLIGVASTGLIGAQLPMDKIKNGLPQLTPTKSDAVTYAVLTTDQHPKTVCVQCELSGQLVTLTGFAKGSGMIHPKMATMLGFVTTDAQIDGPVLQDMLSTNVDQTFNQITVDGDTSTNDMVVTLANGLADNPSLQAGTTDYDIFNQALHYVLGQLAKQIAADGEGATKLVECNVVHAATTFDGQQIAKAIVGSNLVKAAIFGEDPNWGRIISTIGATDADIDVATVDIEMNGVLLVQQSLAVDFDMAAVQATLRDNQIMIDVDLHHGTASGQAWGCDLTYNYVKINASYHT	MSRILLSSLLAAGLFCSLPASAATGCMLFADGSGKPFSAQGDCASQLPPASTFKIPLALMGYDSGFLVDEQLPALPFKAGDPDFLPEWKQTTTPSRWMTYSVIWYSQRLTEWLGAARFQQYVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPQEQARFLGKLVSGKLPVSAQTLQHTANILRQPDIDGWQIHGKTGMGYPKLLDGSLDRDQQIGWFVGWASKQDQKLIFVHTVIQKPGKQFASLRAREEVFAALPEQLKKL	153.03	gnl|BL_ORD_ID|4138|hsp_num:0	5208			147	324	cloxacillin; oxacillin; cefalotin
BGC0000895.1|Citrulline_6 # 7154 # 7900 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.483	BGC0000895.1|Citrulline_6 	7154	7900	+	Loose	700	26.5646	LpsB	40.62	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	ATGACAAAATTGATTGTAATTAAGATTGGGGGCCAGGCGATTAGCCAATTGAGCACCACTTTCTTTGACCAAATCGCACAGTGGTACCAACAGCAGTATCAGATTCTGATCGTACACGGTGGGGGGCCAATGATCAATCGACTGACGACTCAGCTTGCTTTGCCCGTGCATAAGGTGAACGGGTTGCGGGTGACGGATGCGGCGACCTTAGTGCTCACCAAGTTGGCCCTGCTAGGAGATGCGCAACCAGCCTTACTTGCAAAATTAACGCAACATCACCTACCTGTGTTGGGGCTCAATGCGGCGGATAATCAGTTACTAACTGGTGAATTGATTGATTATCGACAGCTAGGGTATGTCGGCCGGCTCACCGCTGTCAATCAAGTGCAATTAATGCAATTGTTGGCTCATCATATCGGTATTTTGGCCCCTTTAGCCTTAACTGAGACGGGACAATGGCTCAATGTCAATGCGGATATGGCAGCGACCGTGCTAGCTCAACAACTACATGCTGAAAAATTGGTTTTGCTAACCGATGTCCCGGGAATTATACATCACGGTAATGTGATGACATCACTATCGCCACAACAAGCTCAGCAATTGATTCGAACAGCTGTGATCACCGCGGGAATGCAACCCAAAGTTCAAGCTGCAATTGCCGCGATTCAGACGGGAGTCAAGCAGGCTATTATTACGAATGCAATCGATCAACCAGGAACCGCAATTATTCAGGAGGTGGCCGTATGA	MTKLIVIKIGGQAISQLSTTFFDQIAQWYQQQYQILIVHGGGPMINRLTTQLALPVHKVNGLRVTDAATLVLTKLALLGDAQPALLAKLTQHHLPVLGLNAADNQLLTGELIDYRQLGYVGRLTAVNQVQLMQLLAHHIGILAPLALTETGQWLNVNADMAATVLAQQLHAEKLVLLTDVPGIIHHGNVMTSLSPQQAQQLIRTAVITAGMQPKVQAAIAAIQTGVKQAIITNAIDQPGTAIIQEVAV	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	67.76	gnl|BL_ORD_ID|2781|hsp_num:0	3793			84	180	colistin A; colistin B; defensin
BGC0000895.1|Citrulline_7 # 7897 # 9066 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.496	BGC0000895.1|Citrulline_7 	7897	9066	+	Loose	1000	27.7202	eptA	24.24	3003576	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGACCATGCAACACGTGTTTCCAACCTATCAACGTTTTCCATTTGCCATTACGGATGGTCAGGGCGTTCATCTGACTGATAATCATGGCAAGACGTATTTAGATTTTACGGCGGGAATCGGGGTCTGCAACTTTGGGTATCACCAGCCACAAATTCAGGCAGCCGTCACCCAGCAGTTGACGCATATCTGGCATACGTCGAATTTATACGAAAATGAATTACAAGATGCCGTTGCCGGCCTGTTAGCGAATGGTGAAGAGCGACTCGTATACTTTGCAAATTCCGGAACCGAAGCTAATGAAGCTGCATTAAAACTCGCACGGAAGTACACGGGTAAAACCGGCATCTTAGCTTTTCAGCATTCATTTCACGGTCGAACCTATGGCGCTATGTCGATGACGGGCAATCCTCATATTCAGGCTGGCTATGCGCCATTAGTGCCTGGCATCACGTTTGCAACCTATAATGACGACGCGGCTTTGGACAAAATCACACCAGAGTTGGCGGCCGTTATTTTAGAAGTCGTTCAAGGTGAAGGCGGCGTCTTTGCGGGACAAACAGCTTGGTTACAAGCGGTTAATGCGAAATGCCAAGCAACGGGTGTTTTGTTGATTATTGATGAGGTGCAGACGGGAATCGGTCGGACTGGTTACCGGATGGCCTATGAAGGTTACGGCCTGGATCCTGATATCTACACGGTCGCCAAGGGCTTAGCGAATGGCTTGCCAGTGGGGGCAATGGTTGGTCGGCGGCAATTAGCCACTGCCTTTGGTCCGGGCAGCCATGGCTCGACGTTCGCCGGTAATGCTGTTGCTATGGCGGCGGCAAAACGTGTCTTGACCCAATTAACACCGGCGCTGTTAACGACGGTTCGAGCCCATGCCAAACTTGTCTGGCAATCCCTAGCGACTCAAGTCGAACCGATACCGGTAGTGAAACAAATCACGGGGAAGGGCCTAATGATTGGAATCCACTTAGATGAACAAATCCCGGTTAATCAAGTCATCACCCGGCTACAAGTAGAAGGCTTATTGACGTTATCAGCTGGCGATAATACGTTACGTTTGTTACCCCCAATTGTGATGCAACCGGCCGATTTATTAGCTGGGATTGCCTTGATTGCAAAGGTACTGACAACTTTGACAACGGAGGTCACGACGAATGAATAA	MTMQHVFPTYQRFPFAITDGQGVHLTDNHGKTYLDFTAGIGVCNFGYHQPQIQAAVTQQLTHIWHTSNLYENELQDAVAGLLANGEERLVYFANSGTEANEAALKLARKYTGKTGILAFQHSFHGRTYGAMSMTGNPHIQAGYAPLVPGITFATYNDDAALDKITPELAAVILEVVQGEGGVFAGQTAWLQAVNAKCQATGVLLIIDEVQTGIGRTGYRMAYEGYGLDPDIYTVAKGLANGLPVGAMVGRRQLATAFGPGSHGSTFAGNAVAMAAAKRVLTQLTPALLTTVRAHAKLVWQSLATQVEPIPVVKQITGKGLMIGIHLDEQIPVNQVITRLQVEGLLTLSAGDNTLRLLPPIVMQPADLLAGIALIAKVLTTLTTEVTTNE	MLKRLLKRPSLNLLAWLLLAAFYISICLNIAFFKQVLQALPLDSLHNVLVFLSMPVVAFSVINIVLTLSSFLWLNRPLACLFILVGAAAQYFIMTYGIVIDRSMIANIIDTTPAESYALMTPQMLLTLGFSGVLAALIACWIKIKPATSRLRSVLFRGANILVSVLLILLVAALFYKDYASLFRNNKELVKSLSPSNSIVASWSWYSHQRLANLPLVRIGEDAHRNPLMQNEKRKNLTILIVGETSRAENFSLNGYPRETNPRLAKDNVVYFPNTASCGTATAVSVPCMFSDMPREHYKEELAQHQEGVLDIIQRAGINVLWNDNDGGCKGACDRVPHQNVTALNLPDQCINGECYDEVLFHGLEEYINNLQGDGVIVLHTIGSHGPTYYNRYPPQFRKFTPTCDTNEIQTCTKEQLVNTYDNTLVYVDYIVDKAINLLKEHQDKFTTSLVYLSDHGESLGENGIYLHGLPYAIAPDSQKQVPMLLWLSEDYQKRYQVDQNCLQKQAQTQHYSQDNLFSTLLGLTGVETKYYQAADDILQTCRRVSE	71.12	gnl|BL_ORD_ID|595|hsp_num:0	516			1116	1401	polymyxin B
BGC0000895.1|Citrulline_10 # 10974 # 11180 # -1 # ID=1_10;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.425	BGC0000895.1|Citrulline_10 	10974	11180	-	Loose	700	23.483	vanS gene in vanC cluster	60.0	3002933	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	GATCTTGCAGCCATGGCTAAGATTATCACGAAATATACTTCAATCGCCGGCTGCCTGACCTTAGACGTCCAAAACGGGACACTCGGTTATCGGACGCTCTTTACCTTGCCAGAAAATGTCGACAGTGAAAAGCTCAAACGAATTATCGACAACTTGAATCGCAAACAATTTAAAGTCATCGAAGTGGAAGATTTACAAGCTGAATAA	DLAAMAKIITKYTSIAGCLTLDVQNGTLGYRTLFTLPENVDSEKLKRIIDNLNRKQFKVIEVEDLQAE	MKNRNPLIRKLLTQYFVTTGILLAFLVMIPLVIRFIAGTRTWYGTEPIYYILRFFADRWLFCVAIGALLIWFGTTIYYMTKAIGYLNETIQATTQLIEEPSKRITLSSHLIDVQEEMNQLREKSLQDQRAAKEAEQRKNDLIVYLAHDLRTPLTSVIGYLTLLKEEPQLSNAMRNRYTEIALQKAQRLELLISEFFEITRFNLTTIVLQTETTDLSLMLEQLTFEFLPLLEEKNLNWQLNLQKNVLATVDTEKIARVFDNLIRNAINYSYPDSPLLLELVESDSIHIRLTNRGKTIPEEMIGRLFEPFYRMDSSRATATSGTGLGLPIAKEILLASGGDISAESKDETIIFNVRLPKPANN	18.84	gnl|BL_ORD_ID|904|hsp_num:0	966			744	789	vancomycin
